“…Historically, the [N–I–N] + iodine(I) complexes have overwhelmingly existed as homoleptic species incorporating aromatic Lewis bases, ,,,,− i.e., [L1–I–L1] + (L = Lewis base), including the eponymous Barluenga’s reagent [py–I–py]BF 4 (py = pyridine) . While a few examples of heteroleptic, [L1–I–L2] + , iodine(I) complexes do exist in the solid state, , these have been found to be susceptible to ligand scrambling in solution, often resulting in mixtures also containing the disproportionation products [L1–I–L1] + and [L2–I–L2] + , , though recently this problem has been deftly side-stepped for pairs of monotopic ligands via the inducement of axial chirality in homoleptic complexes . On the other hand, hypoiodites of the form the RC(O)O–I–L are inherently heteroleptic in their substituents, offering a greater variety of options for modifying their substituents and ultimately tuning their properties, such as the first chiral hypoiodite complexes being recently reported based on chiral N-protected amino acids …”